These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 9338485

  • 1. Enhancement of Burkholderia cepacia antimicrobial susceptibility by cationic compounds.
    Rajyaguru JM, Muszynski MJ.
    J Antimicrob Chemother; 1997 Sep; 40(3):345-51. PubMed ID: 9338485
    [Abstract] [Full Text] [Related]

  • 2. Sensitization of Burkholderia cepacia to antibiotics by cationic drugs.
    Rajyaguru JM, Muszynski MJ.
    J Antimicrob Chemother; 1998 Feb; 41(2):277-80. PubMed ID: 9533472
    [Abstract] [Full Text] [Related]

  • 3. Post-antibiotic effect of ceftazidime, ciprofloxacin, imipenem, piperacillin and tobramycin for Pseudomonas cepacia.
    Kumar A, Hay MB, Maier GA, Dyke JW.
    J Antimicrob Chemother; 1992 Nov; 30(5):597-602. PubMed ID: 1283606
    [Abstract] [Full Text] [Related]

  • 4. Association of resistance to trimethoprim/sulphamethoxazole, chloramphenicol and quinolones with changes in major outer membrane proteins and lipopolysaccharide in Burkholderia cepacia.
    Rajyaguru JM, Muszynski MJ.
    J Antimicrob Chemother; 1997 Dec; 40(6):803-9. PubMed ID: 9462431
    [Abstract] [Full Text] [Related]

  • 5. Antibacterial properties of investigational, new, and commonly used antibiotics against isolates of Pseudomonas cepacia in Michigan.
    Bhakta DR, Leader I, Jacobson R, Robinson-Dunn B, Honicky RE, Kumar A.
    Chemotherapy; 1992 Dec; 38(5):319-23. PubMed ID: 1283733
    [Abstract] [Full Text] [Related]

  • 6. The effect of cationic microbicide exposure against Burkholderia cepacia complex (Bcc); the use of Burkholderia lata strain 383 as a model bacterium.
    Knapp L, Rushton L, Stapleton H, Sass A, Stewart S, Amezquita A, McClure P, Mahenthiralingam E, Maillard JY.
    J Appl Microbiol; 2013 Nov; 115(5):1117-26. PubMed ID: 23910391
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Comparative in vitro activities of meropenem, imipenem, temocillin, piperacillin, and ceftazidime in combination with tobramycin, rifampin, or ciprofloxacin against Burkholderia cepacia isolates from patients with cystic fibrosis.
    Bonacorsi S, Fitoussi F, Lhopital S, Bingen E.
    Antimicrob Agents Chemother; 1999 Feb; 43(2):213-7. PubMed ID: 9925508
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Effect of polysaccharide interactions on antibiotic susceptibility of Pseudomonas aeruginosa.
    Allison DG, Matthews MJ.
    J Appl Bacteriol; 1992 Dec; 73(6):484-8. PubMed ID: 1283390
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Antimicrobial resistance and DNA-fingerprinting pattern of Burkholderia cepacia blood isolates.
    Saika T, Kobayashi I, Hasegawa M, Nishida M.
    J Infect Chemother; 2002 Dec; 8(4):341-4. PubMed ID: 12525895
    [Abstract] [Full Text] [Related]

  • 15. Use of the E test to assess synergy of antibiotic combinations against isolates of Burkholderia cepacia-complex from patients with cystic fibrosis.
    Manno G, Ugolotti E, Belli ML, Fenu ML, Romano L, Cruciani M.
    Eur J Clin Microbiol Infect Dis; 2003 Jan; 22(1):28-34. PubMed ID: 12582741
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.